BRPI0607214A2 - derivados de 2-(4-cianofenilamino) pirimidina inibidores de hiv - Google Patents

derivados de 2-(4-cianofenilamino) pirimidina inibidores de hiv

Info

Publication number
BRPI0607214A2
BRPI0607214A2 BRPI0607214-3A BRPI0607214A BRPI0607214A2 BR PI0607214 A2 BRPI0607214 A2 BR PI0607214A2 BR PI0607214 A BRPI0607214 A BR PI0607214A BR PI0607214 A2 BRPI0607214 A2 BR PI0607214A2
Authority
BR
Brazil
Prior art keywords
cyanophenylamino
pyrimidine derivatives
hiv inhibitors
compounds
derivatives hiv
Prior art date
Application number
BRPI0607214-3A
Other languages
English (en)
Inventor
Adrian Jan Janssen Paul
Jan Heeres
Rudolf Leemans
Luc Jozef Raphael Moens
Paulus Joannes Lewi
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of BRPI0607214A2 publication Critical patent/BRPI0607214A2/pt
Publication of BRPI0607214B1 publication Critical patent/BRPI0607214B1/pt
Publication of BRPI0607214B8 publication Critical patent/BRPI0607214B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50—Three nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

DERIVADOS DE 2-(4-CIANOFENILAMINO)PIRIMIDINA INIBIDORES DE HIV. Inibidores de replicação de HIV de fórmula (1), sais de adição farmaceuticamente aceitáveis ou formas este reoquim icamente isoméricas destes, em que X é NR4, S, SO ou S02; a preparação destes compostos assim como composições farmacêuticas compreendendo estes compostos; o uso destes compostos para a prevenção ou o tratamento de infecção por HIV.
BRPI0607214A 2005-01-27 2006-01-27 derivados de 2-(4-cianofenilamino)pirimidina inibidores de hiv, composição farmacêutica que os compreende e seus processos de preparação BRPI0607214B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05100521 2005-01-27
PCT/EP2006/050490 WO2006079656A1 (en) 2005-01-27 2006-01-27 Hiv inhibiting 2-( 4-cyanophenylamino) pyrimidine derivatives

Publications (3)

Publication Number Publication Date
BRPI0607214A2 true BRPI0607214A2 (pt) 2009-08-18
BRPI0607214B1 BRPI0607214B1 (pt) 2019-09-10
BRPI0607214B8 BRPI0607214B8 (pt) 2021-05-25

Family

ID=34938584

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0607214A BRPI0607214B8 (pt) 2005-01-27 2006-01-27 derivados de 2-(4-cianofenilamino)pirimidina inibidores de hiv, composição farmacêutica que os compreende e seus processos de preparação

Country Status (12)

Country Link
US (1) US20090124644A1 (pt)
EP (2) EP2388249A1 (pt)
JP (2) JP5190272B2 (pt)
CN (1) CN101107234B (pt)
AT (1) ATE523498T1 (pt)
AU (1) AU2006208778B2 (pt)
BR (1) BRPI0607214B8 (pt)
CA (1) CA2599228C (pt)
ES (1) ES2373820T3 (pt)
MX (1) MX2007009015A (pt)
RU (1) RU2403245C2 (pt)
WO (1) WO2006079656A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7935711B2 (en) * 2005-02-18 2011-05-03 Tibotec Pharmaceuticals Ltd. HIV inhibiting 2-(4-cyanophenylamino) pyrimidine oxide derivatives
EP1947097A1 (en) * 2005-10-27 2008-07-23 Teijin Pharma Limited BENZOÝb¨THIOPHEN DERIVATIVE AND PROCESS FOR PRODUCTION THEREOF
ES2523863T3 (es) * 2006-12-29 2014-12-02 Janssen R&D Ireland Pirimidinas 5,6-sustituidas inhibidoras del VIH
BRPI0720858B8 (pt) * 2006-12-29 2021-05-25 Janssen R & D Ireland pirimidinas 6-substituídas inibidoras de hiv e composição farmacêutica que as compreende
US20110196156A1 (en) * 2009-06-22 2011-08-11 Mukund Keshav Gurjar Process for synthesis of diarylpyrimidine non-nucleoside reverse transcriptase inhibitor
US8153790B2 (en) 2009-07-27 2012-04-10 Krizmanic Irena Process for the preparation and purification of etravirine and intermediates thereof
CN102731414B (zh) * 2012-07-04 2014-11-26 宁波九胜创新医药科技有限公司 4-[(4-氯-2-嘧啶基)氨基]苯腈的制备方法
CN102718720B (zh) * 2012-07-04 2015-01-07 宁波九胜创新医药科技有限公司 4-[(4,6-二氯-2-嘧啶基)氨基]苯腈的制备方法
WO2014072419A1 (en) 2012-11-08 2014-05-15 Universiteit Antwerpen Novel anti-hiv compounds
RU2729792C1 (ru) * 2019-07-29 2020-08-12 Акционерное общество "Научно-производственное объединение "ДОМ ФАРМАЦИИ" Способы повышения растворимости лекарственного средства на основе пиримидинового производного бензофенона

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459731A (en) 1966-12-16 1969-08-05 Corn Products Co Cyclodextrin polyethers and their production
EP0862463A1 (en) 1995-11-23 1998-09-09 Janssen Pharmaceutica N.V. Solid mixtures of cyclodextrins prepared via melt-extrusion
SK287269B6 (sk) * 1998-11-10 2010-05-07 Janssen Pharmaceutica N. V. Derivát pyrimidínu, jeho použitie, spôsob jeho prípravy a farmaceutická kompozícia, kombinácia a produkt s jeho obsahom
US20050239054A1 (en) * 2002-04-26 2005-10-27 Arimilli Murty N Method and compositions for identifying anti-HIV therapeutic compounds

Also Published As

Publication number Publication date
EP2388249A1 (en) 2011-11-23
MX2007009015A (es) 2007-09-18
JP2008528554A (ja) 2008-07-31
CN101107234A (zh) 2008-01-16
EP1853568B1 (en) 2011-09-07
EP1853568A1 (en) 2007-11-14
RU2007132179A (ru) 2009-03-10
ES2373820T3 (es) 2012-02-09
AU2006208778B2 (en) 2012-08-09
JP5190272B2 (ja) 2013-04-24
AU2006208778A1 (en) 2006-08-03
CN101107234B (zh) 2013-06-19
ATE523498T1 (de) 2011-09-15
JP2013082722A (ja) 2013-05-09
CA2599228A1 (en) 2006-08-03
CA2599228C (en) 2014-05-13
US20090124644A1 (en) 2009-05-14
WO2006079656A1 (en) 2006-08-03
BRPI0607214B1 (pt) 2019-09-10
BRPI0607214B8 (pt) 2021-05-25
RU2403245C2 (ru) 2010-11-10

Similar Documents

Publication Publication Date Title
DK1487444T3 (da) Anvendelse af pyridylamider som angiogeneseinhibitorer
UY30274A1 (es) Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones
CY1111693T1 (el) Αντιιικοι παραγοντες
BR0316771A (pt) Compostos para o tratamento ou a prevenção de infecções por flavivirus, uso de um composto e composição farmacêutica
UY29927A1 (es) Derivados sustituidos de la 5-fenil-2-tioxo-imidazolin-4-ona y de la 5-fenil-2-amino-imidazolidin-4-ona y sus sales, composiciones y aplicaciones
SE0402735D0 (sv) Novel compounds
PL369108A1 (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
UY29919A1 (es) Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones
MX2008013836A (es) Derivados de 2-piridona para el tratamiento de enfermedades o condiciones en las cuales es benefica la inhibicion de la actividad de elastasa de neutrofilos.
SG170101A1 (en) 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
UY30025A1 (es) Derivados sustituidos de las 2-amino-5,6-dihidro pirimidin-4(3h)-onas y sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones.
BR0313407A (pt) Novo uso de derivados de benzotiazol
WO2006027628A3 (en) Naphthalimide derivatives as antiviral agents
DE602007001463D1 (de) Pyrimidin-, chinazolin-, pteridin- und triazinderivate
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
NO20063275L (no) Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom
WO2009013348A3 (en) Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions
SE0301232D0 (sv) Novel use
EA200971086A1 (ru) Фармацевтические композиции и способ лечения шизофрении
TW200640879A (en) Amide derivatives
BRPI0607214A2 (pt) derivados de 2-(4-cianofenilamino) pirimidina inibidores de hiv
ATE449776T1 (de) Pyrroloä2,3-cüpyridinderivate
BR0314860A (pt) Derivados de pirazol
ATE473212T1 (de) Hiv-inhibierende 2-(4-cyanophenyl)-6- hydroxylaminopyrimidine
BRPI0411208A (pt) uso de derivados 2-amino-1,3-propanodiol para a fabricação de um medicamento para o tratamento de vários tipos de dor

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: TIBOTEC PHARMACEUTICALS (IE)

B25D Requested change of name of applicant approved

Owner name: JANSSEN R AND D IRELAND (IE)

B25A Requested transfer of rights approved

Owner name: JANSSEN SCIENCES IRELAND UC (IE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/09/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/09/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/01/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2707 DE 22-11-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.